Integration of Checkpoint Inhibitors into the Management of Locally Advanced Head and Neck Cancer - Future Perspectives.

Brooker, R C; Sacco, J J; Schache, A G

Brooker, R C; Sacco, J J; Schache, A G.

Afiliación

Brooker RC; The Department of Molecular and Clinical Cancer Medicine, The Northwest Cancer Research Centre, University of Liverpool, Liverpool, UK; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK. Electronic address: Rachel.brooker@liverpool.ac.uk.
Sacco JJ; The Department of Molecular and Clinical Cancer Medicine, The Northwest Cancer Research Centre, University of Liverpool, Liverpool, UK; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK.
Schache AG; The Department of Molecular and Clinical Cancer Medicine, The Northwest Cancer Research Centre, University of Liverpool, Liverpool, UK; Head and Neck Unit, Aintree University Hospital NHS Foundation Trust, Liverpool, UK.

Clin Oncol (R Coll Radiol) ; 31(7): 424-431, 2019 07.

Article en En | MEDLINE | ID: mdl-31097366

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google